Lyell Immunopharma | 424B5:募資說明書
20:14
Lyell Immunopharma | 10-Q:季度報表
20:09
Lyell Immunopharma | 8-K:Lyell Immunopharma報告2024年第一季度的業務亮點和財務業績
20:03
Lyell Immunopharma | EFFECT:其他
18:18
Lyell Immunopharma | ARS:年度報告
04/23 04:22
Lyell Immunopharma | DEFA14A:其他
04/23 04:22
Lyell Immunopharma | DEF 14A:股東委託書決議
04/23 04:17
Lyell Immunopharma | S-3:特定交易註冊聲明
03/01 02:35
Lyell Immunopharma | S-8:員工福利計劃證券登記
03/01 02:35
Lyell Immunopharma | 10-K:年度報表
02/29 11:28
Lyell Immunopharma | 8-K:Lyell Immunopharma報告了2023年第四季度和全年業務亮點和財務業績
02/29 05:15
Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
02/15 04:24
Lyell Immunopharma | 4:持股變動聲明-高管 Lang Matthew
02/14 09:31
Lyell Immunopharma | 4:持股變動聲明-高管 Hill Stephen J.
02/14 09:26
Lyell Immunopharma | 4:持股變動聲明-高管 Lee Gary K.
02/14 09:26
Lyell Immunopharma | 4:持股變動聲明-高管 Newton Charles W.
02/14 09:21
Lyell Immunopharma | 4:持股變動聲明-高管 Seely Lynn
02/14 09:21
Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.40%)
02/14 06:52
Lyell Immunopharma | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.7%)
01/30 06:37
Lyell Immunopharma | 4:持股變動聲明-首席財務官 Newton Charles W.
2023/11/21 09:55
暫無數據
暫無數據